ArticleMolecular biology reports2026
Evaluation of phytochemical-mediated inhibition of the efflux pump in Pseudomonas aeruginosa PAO1.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
Abstract
backgroundNatural bioactive compounds derived from plants have gained considerable attention due to their potential therapeutic and medicinal applications. In the context of antimicrobial resistance, these compounds are being explored as potential efflux pump inhibitors (EPIs) and antibiotic adjuvants to enhance antimicrobial efficacy. Their low toxicity and broad availability make them promising candidates for the development of alternative therapeutic strategies against multidrug-resistant (MDR) pathogens such as Pseudomonas aeruginosa.
methodsThis study evaluated the efflux pump inhibitory activity of selected phytochemicals Mirificin, Forsythoside A, Salvianolic acid A, Epigallocatechin gallate, and Epicatechin gallate against Pseudomonas aeruginosa. A range of in vitro analyses were employed, including biofilm inhibition assays, fluorescence-based efflux assays (using Ethidium Bromide, N-phenyl-1-naphthylamine and Hoechst dye accumulation), advanced imaging techniques and qRT-PCR assays to assess their efflux pump inhibitory potential comprehensively.
resultsThe results demonstrated a dose-dependent inhibition of biofilm formation, with more than a 75% reduction in biofilm biomass observed at higher treatment concentrations. The tested phytochemicals significantly enhanced the intracellular accumulation of both Ethidium Bromide and Hoechst dye, indicating effective inhibition of efflux pump activity. Among the tested compounds, Salvianolic acid A (at 100 µM) exhibited the highest inhibitory activity, achieving a level comparable to the positive control, PAβN. RT-PCR analysis confirmed this activity at the transcriptional level, showing significant downregulation of the efflux pump genes mexA, mexB, and oprM, along with the quorum sensing genes rhlI and rhlR, following treatment with Salvianolic acid A.
conclusionsCollectively, these results position Salvianolic acid A and the other phytochemicals evaluated here as promising adjuvant candidates for tackling multidrug-resistant Pseudomonas aeruginosa, and warrant their continued investigation as adjunctive therapeutic options alongside conventional antibiotics.
Indexed as
Identifiers
42663771What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.